SCHEMBL10134566

SCHEMBL10134566

CCN(CC)c1ccc2cc(C(=O)NCC(C)(C)OCC(C)(C)C(=O)NCCc3ccc(O)cc3)c(=O)oc2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKR1B10 O60218 7/20 0.54
▸ AKR1B1 P15121 6/20 0.54
▸ AKR1A1 P14550 2/20 0.48
▸ CBR1 P16152 2/20 0.48
▸ AKR1C4 P17516 2/20 0.48
▸ AKR1C3 P42330 2/20 0.48
▸ AKR1C2 P52895 2/20 0.48
▸ AKR1C1 Q04828 2/20 0.48
▸ KMT2A Q03164 4/20 0.47
▸ MEN1 O00255 3/20 0.47
▸ MAPT P10636 3/20 0.47
▸ ALDH1A1 P00352 3/20 0.47
▸ SMN1; SMN2 Q16637 3/20 0.47
▸ MAOB P27338 3/20 0.47
▸ ATM Q13315 3/20 0.47
▸ KDM4E B2RXH2 2/20 0.47
▸ HPGD P15428 2/20 0.47
▸ USP2 O75604 1/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15298966 0.85 AKR1B10 (0.74) AKR1B10AKR1B1AKR1A1CBR1AKR1C4
SCHEMBL47328 0.81 AKR1B10 (0.51) AKR1B10AKR1B1AKR1A1CBR1AKR1C4
SCHEMBL19828570 0.78 KMT2A (0.52) KMT2AMEN1MAPTALDH1A1SMN1; SMN2
SCHEMBL43817 0.77 AKR1B10 (0.59) AKR1B10AKR1B1AKR1A1CBR1AKR1C4
SCHEMBL9303724 0.73 KMT2A (0.70) KMT2AMEN1MAPTALDH1A1SMN1; SMN2
SCHEMBL16293207 0.73 KMT2A (0.73) KMT2AMEN1MAPTALDH1A1SMN1; SMN2
SCHEMBL13403918 0.72 KMT2A (0.71) KMT2AMEN1MAPTALDH1A1SMN1; SMN2
SCHEMBL14155417 0.72 KMT2A (0.53) KMT2AMEN1MAPTALDH1A1SMN1; SMN2
SCHEMBL8398863 0.71 KMT2A (0.60) KMT2AMEN1MAPTALDH1A1SMN1; SMN2
SCHEMBL13081989 0.70 KMT2A (0.70) KMT2AMEN1MAPTALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012003476-A2 HAPTEN CONJUGATES FOR TARGET DETECTION VENTANA MEDICAL SYSTEMS, INC. (US) 2012-01-05 — — WO disclosed
Send feedback